Lotilaner

Lotilaner (CAS 1398609-39-6) is a systemic isoxazoline ectoparasiticide developed for veterinary use, primarily in dogs and cats. It acts by inhibiting GABA- and glutamate-gated chloride channels, leading to rapid paralysis and death of fleas and ticks. This compound is characterized by its high potency and prolonged duration of action, making it a preferred choice in oral formulations for ectoparasite control.

We supply Lotilaner as a white to off-white powder with a purity of ≥98% (HPLC), suitable for pharmaceutical formulation and veterinary product development. Each batch is accompanied by a COA, MSDS, and TDS, ensuring traceability and compliance with regulatory standards.

Sinonimi: Lotilaner, 4-[(5RS)-5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-N-[(4-methoxyphenyl)methyl]-2-methylbenzamide

Applicazioni

• Veterinary oral solutions for flea and tick control in dogs and cats
• Combination products with other antiparasitic agents
• R&D for novel ectoparasiticide formulations

Qualità e documentazione

Every batch is tested for assay (HPLC ≥98%), loss on drying (≤0.5%), and heavy metals (≤10 ppm). Full COA, MSDS, and TDS are available on request. Stability data can be provided to support your qualification and registration processes.

Imballaggio e forniture

Confezioni standard: 1 kg, 5 kg, 25 kg; disponibili anche confezioni sfuse e personalizzate. Gli articoli disponibili a magazzino vengono spediti entro 3-5 giorni; quantità minima ordinabile (MOQ) a partire da 1 kg. Per informazioni sui prezzi, sui campioni e sugli ordini all’ingrosso, contattate il nostro team commerciale.

Richiesta di preventivo

• Il nostro indirizzo: 280 Main Street, Xian, Shaanxi, Cina
• LyvBio S.r.l. — E-mail: info@lyvbio.com